Stay updated on Empowur Safety in OAB Clinical Trial
Sign up to get notified when there's something new on the Empowur Safety in OAB Clinical Trial page.

Latest updates to the Empowur Safety in OAB Clinical Trial page
- Check3 days agoChange DetectedThe clinical trial record for the completed vibegron extension study is displayed, with its study details, participant criteria, locations, and outcome measures.SummaryDifference95%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual study details with a minimal error view and a Home link. This indicates an access or server issue that prevents viewing the trial information.SummaryDifference17%

Stay in the know with updates to Empowur Safety in OAB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empowur Safety in OAB Clinical Trial page.